Skip to main content

Injectable Treatments for Fat

  • Chapter
  • First Online:
Update in Cosmetic Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ablon G, Rotunda AM (2004) Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 30:422–427

    Article  PubMed  Google Scholar 

  2. American Society for Dermatologic Surgery (2005) Emerging technology report: ­mesotherapy. Available at: http://www.asds-net.org/Media/PositionStatements/emerging_technology-­mesotherapy.html. Accessed 15 June 2009

  3. American Society for Aesthetic Plastic Surgery (2007) American Society for Aesthetic Plastic Surgery warns patients to steer clear of injection fat loss treatments. Available at: http://www.surgery.org/press/news-release.php?iid1/4475. Accessed 15 June 2009

  4. Amin SP, Phelps RG, Goldberg DJ (2006) Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg 32:1467–1472

    Article  PubMed  CAS  Google Scholar 

  5. Atiyeh BS, Ibrahim AE, Dibo SA (2008) Cosmetic mesotherapy: between scientific evidence, science fiction, and lucrative business. Aesthetic Plast Surg 32:842–849

    Article  PubMed  Google Scholar 

  6. Bangham JA, Lea EJ (1978) The interaction of detergents with bilayer lipid membranes. Biochim Biophys Acta 511:388–396

    Article  PubMed  CAS  Google Scholar 

  7. Bechara FG, Sand M, Hoffmann K et al (2007) Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study. J Cutan Pathol 34:552–557

    Article  PubMed  Google Scholar 

  8. Beer K, Waibel J (2009) Disfiguring scarring following mesotherapy associated Mycobacterium cosmeticum infection. J Drugs Dermatol 8:391–393

    PubMed  Google Scholar 

  9. Bentow J, Suzuki H, Nahmood N et al (2009) Phosphatidylcholine inhibits the adipolytic activity of deoxycholate in vitro and in vivo. The 5th Continent Congress. Abstract

    Google Scholar 

  10. Boodman SG (2007) Can shots safely ‘Melt Away Fat’? Washington Post. Available at: http://www.washingtonpost.com/wp-dyn/content/article/2007/06/22/AR2007062201870.html. Accessed 15 June 2009

  11. Carbonne A, Brossier F, Arnaud I et al (2009) Outbreak of nontuberculous Mycobacterial subcutaneous infections related to multiple mesotherapy injections. J Clin Microbiol 47:1961–1964

    Article  PubMed  Google Scholar 

  12. Cacchio A, De Blasis E, Desiati P et al (2009) Effectiveness of treatment of calcific tendinitis of the shoulder by disodium EDTA. Arthritis Rheum 15:84–91

    Google Scholar 

  13. Consumer Safety Alert on Fat Dissolving Injections (2007) Available at: http://www.prnewswire.com. Accessed 15 June 2009

  14. Davis MD, Wright TI, Shehan JM (2008) A complication of mesotherapy: noninfectious granulomatous panniculitis. Arch Dermatol 144:808–809

    Article  PubMed  Google Scholar 

  15. Duncan DI, Hasengschwandtner F (2005) Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthetic Surg J 25:530–543

    Article  CAS  Google Scholar 

  16. Duncan D, Rubin JP, Golitz L, Badylak S, Kesel L, Freund J, Duncan D et al (2009) Refinement of technique in injection lipolysis based on scientific studies and clinical evaluation. Clin Plast Surg 36:195–209

    Article  PubMed  Google Scholar 

  17. Duncan D (2005) Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthetic Surg J 25:530–543

    Article  CAS  Google Scholar 

  18. Durr M, Hager J, Lohr JP (1994) Investigations on mixed micelle and liposome preparations for parenteral use based on soya phosphatidylcholine. Eur J Biopharma 40:147–156

    Google Scholar 

  19. Goldman MP (2004) Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe? Dermatol Surg 30:1454–1456

    Article  PubMed  Google Scholar 

  20. Greenway FL, Bray GA (1987) Regional fat loss from the thigh in obese women after adrenergic modulation. Clin Ther 9:663–669

    PubMed  CAS  Google Scholar 

  21. Gupta A, Lobocki C, Singh S et al (2009) Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cell types. Aesthetic Plast Surg 33:346–352

    Article  PubMed  CAS  Google Scholar 

  22. Hexsel DM, Serra M, de Oliveira Dal’Forno T et al (2003) Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2:511–518

    PubMed  Google Scholar 

  23. Hexsel DM, Serra M, de Oliveira Dal’Forno T, Zechmeister do Prado D (2005) Cosmetic uses of injectable PC on the face. Otolarngol Clin N Am 38:1119–1129

    Article  Google Scholar 

  24. Janke J, Engeli S et al (2009) Compounds used for injection lipolysis destroy adipocytes and other cells found in adipose tissue. Obes Facts 2:36–39

    Article  PubMed  Google Scholar 

  25. Jones MN (1999) Surfactants in membrane solubilisation. Int J Pharm 177:137–159

    Article  PubMed  CAS  Google Scholar 

  26. KCTV 5 News (2007) Lipodissolve company to file bankruptcy. Available at: http://www.kctv5.com/news/14822891/detail.html. Accessed 15 June 2009

  27. Klein SM, Schreml S, Nerlich M et al (2009) In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution? Plast Reconstr Surg 124:419–427

    Article  PubMed  CAS  Google Scholar 

  28. Kopera D, Binder B, Toplak H (2006) Intralesional lipolysis with phosphatidylcholine for the treatment of lipomas: pilot study. Arch Dermatol 142:395–396

    Article  PubMed  Google Scholar 

  29. Kythera Biopharmaceuticals. Available at: http://www.kytherabiopharma.com/newsroom/. Accessed 13 Feb 2011

  30. Lacarrubba F, Tedeschi A, Nardone B et al (2008) Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther 21:S1–S5

    Article  PubMed  Google Scholar 

  31. Lee JH, Park JG, Lim SH et al (2006) Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 32:626–631

    Article  PubMed  CAS  Google Scholar 

  32. Lichtenberg D (1985) Characterization of the solubilization of lipid bilayers by surfactants. Biochim Biophys Acta 821:470–478

    Article  PubMed  CAS  Google Scholar 

  33. Lichtenberg D, Zilberman Y, Greenzaid P et al (1979) Structural and kinetic studies on the solubilization of lecithin by sodium deoxycholate. Biochemistry 18:3517–3525

    Article  PubMed  CAS  Google Scholar 

  34. Matarasso A, Pfeifer TM (2009) Mesotherapy and injection lipolysis. Clin Plast Surg 36:181–192

    Article  PubMed  Google Scholar 

  35. Motolese P (2008) Phospholipids do not have lipolytic activity. A critical review. J Cosmet Laser Ther 10:114–118

    Article  PubMed  Google Scholar 

  36. Myers P (2006) The cosmetic use of phosphatidylcholine in the treatment of localized fat deposits. Cosmet Dermatol 19:4120–4160

    Google Scholar 

  37. Palmer M, Curran J, Bowler P (2006) Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: a multicentre, retrospective UK study. J Cosmet Dermatol 5:218–226

    Article  PubMed  Google Scholar 

  38. Park SH, Kim DW, Lee MA et al (2008) Effectiveness of mesotherapy on body contouring. Plast Reconstr Surg 121:179e–185e

    Article  PubMed  CAS  Google Scholar 

  39. Pistor M (1964) Mesotherapy. Librairie Maloine S.A., Paris

    Google Scholar 

  40. Rang HP, Dale MM, Ritter JM et al (2003) Chapter 11: Pharmacology. Elsevier Churchill Livingstone, Philadelphia

    Google Scholar 

  41. Redman LM, Moro C, Dobak J et al (2011) Association of beta-2 adrenergic agonist and corticosteroid injection in the treatment of lipomas. Diabetes Obes Metab 13:517–522

    Article  PubMed  CAS  Google Scholar 

  42. Rittes PG (2001) The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 27:391–392

    Article  PubMed  CAS  Google Scholar 

  43. Rittes PG (2007) Complications of Lipostabil Endova for treating localized fat deposits. Aesthetic Surg J 27:146–149

    Article  CAS  Google Scholar 

  44. Rittes PG, Rittes JC, Carriel Amary MF (2006) Injection of phosphatidylcholine in fat tissue: experimental study of local action in rabbits. Aesthetic Plast Surg 30:474–478

    Article  PubMed  Google Scholar 

  45. Rittes PG (2009) The lipodissolve technique: clinical experience. Clin Plast Surg 36:215–221

    Article  PubMed  Google Scholar 

  46. Rotunda AM, Avram MM, Avram AS (2005) Cellulite: is there a role for injectables? J Cosmet Laser Ther 7:147–154

    Article  PubMed  Google Scholar 

  47. Rotunda AM, Avram MM (2009) The importance of caution in the use of unregulated anticellulite treatments. Arch Dermatol 145:337

    Article  PubMed  Google Scholar 

  48. Rotunda AM, Commentary to Schuller-Petrovic et al (2008) Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatol Surg 34:534–535

    Google Scholar 

  49. Rotunda AM, Kolodney MS (2006) Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 32:465–480

    Article  PubMed  CAS  Google Scholar 

  50. Rotunda AM, Weiss SR, Rivkin LS (2009) Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat. Dermatol Surg 35:792–803

    Article  PubMed  CAS  Google Scholar 

  51. Rotunda AM, Ablon G, Kolodney MS (2005) Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 53:973–978

    Article  PubMed  Google Scholar 

  52. Rotunda AM, Jones DH (2010) HIV-associated lipohypertrophy (buccal fat-pad lipoma-like lesions) reduced with subcutaneously injected sodium deoxycholate. Dermatol Surg 36:1348–1354

    Article  PubMed  CAS  Google Scholar 

  53. Rotunda AM, Suzuki H, Moy RL et al (2004) Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 30:1001–1008

    Article  PubMed  Google Scholar 

  54. Rundle RL (2007) Popular treatment that aims to melt fat draws scrutiny. Wall Street Journal. Available at: http://online.wsj.com/article/SB118160554567831887.html?mod1/4home_health_right. Accessed 15 June 2009

  55. Salti G, Ghersetich I, Tantussi F et al (2008) Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study. Dermatol Surg 34:60–66

    Article  PubMed  CAS  Google Scholar 

  56. Schuller-Petrovic S, Wolkart G, Hofler G et al (2008) Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatol Surg 34:524–529

    Article  Google Scholar 

  57. Thuangtong R, Bentow JJ, Knopp K et al (2010) Tissue-selective effects of injected deoxycholate. Dermatol Surg 36:899–908

    Article  PubMed  CAS  Google Scholar 

  58. Tisi PV, Beverley C, Rees A (2006) Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev 4:CD001732

    Google Scholar 

  59. Treacy P, Goldberg D (2006) Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. J Cosmet Laser Ther 8:129–132

    Article  PubMed  Google Scholar 

  60. United States Food and Drug Administration (USFDA) (2008) Statement on lipo dissolve. Available at: http://www.fda.gov. Accessed 15 June 2009

  61. Yagina Odo YME, Cuce LC, Odo LM et al (2007) Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects. Dermatol Surg 33:178–188

    Article  Google Scholar 

Download references

Disclosure

Dr. Rotunda is the coinventor of several patents that describe methods to reduce subcutaneous fat with deoxycholate. Dr. Rotunda is a consultant to KYTHERA Biopharmaceuticals, Lithera, and Allergan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam M. Rotunda M.D., F.A.A.D., F.A.C.M.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rotunda, A.M. (2013). Injectable Treatments for Fat. In: Tosti, A., Hexsel, D. (eds) Update in Cosmetic Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34029-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-34029-1_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-34028-4

  • Online ISBN: 978-3-642-34029-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics